TNBC
Clinical trials for TNBC explained in plain language.
Never miss a new study
Get alerted when new TNBC trials appear
Sign up with your email to follow new studies for TNBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to wipe out early TNBC before surgery
Disease control Not yet recruitingThis study tests whether giving a combination of the immunotherapy drug camrelizumab, chemotherapy, and targeted radiation before surgery can eliminate all signs of cancer in women with early-stage triple-negative breast cancer. About 43 women aged 18-75 with newly diagnosed, unt…
Matched conditions: TNBC
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
Gut bacteria boosts breast cancer treatment? new trial launches
Disease control Not yet recruitingThis phase 2 trial tests whether adding a live bacteria supplement (MO-03) to standard chemotherapy and immunotherapy (pembrolizumab) can improve outcomes for 50 people with early-stage triple-negative breast cancer. Participants take the supplement twice daily until surgery, the…
Matched conditions: TNBC
Phase: PHASE2 • Sponsor: Yuan Yuan • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
New hope for hard-to-treat breast cancer? drug duo targets PIK3CA mutation
Disease control Not yet recruitingThis study tests a combination of two drugs (inavolisib and eribulin) in people with advanced triple-negative breast cancer that has a specific genetic change called PIK3CA mutation. The goal is to see if the combo can shrink tumors. About 26 participants who have already tried a…
Matched conditions: TNBC
Phase: PHASE2 • Sponsor: Hu Hai • Aim: Disease control
Last updated May 04, 2026 16:18 UTC